LG Chem is making progress in the development of the world's first oral treatment for rare forms of obesity.
Novo Nordisk’s GLP-1 Ozempic has reported a YoY increase in revenue from $2.1 billion to $3.2 billion
GL0034 is a novel, investigational glucagon-like peptide 1 receptor agonist (GLP-1RA) being studied for the treatment of type 2 diabetes and obesity
The Allurion Program is suited for people who are unable to achieve their weight-loss goals by dieting alone or for those who do not want to, or cannot, undergo invasive surgery or endoscopy
Man lost 54 Kgs in 6 months with MGB procedure
The funds raised in the seed round will be used for research and development of Shri Chyawan Ayurved Product
MedTel aims to raise series A for rapid business expansion, product improvement & conducting relevant clinical validation studies.
Each member of Fitelo's team of experts gives highly personalized attention and recommendations to their clients ensuring they reach their fitness goals holis
The study was published recently in Genome Medicine, a leading international journal focused on translational, genomic-based medicine
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
